Fremanezumab OverviewFremanezumab (INN) is a humanized monoclonal antibody directed against calcitonin-related polypeptides (CGRP) alpha and beta. It was originated by Rinat Neuroscience Corporation, which licensed it to Teva. In 2018 Teva stopped development of fremanezumab for the treatment of chronic cluster headache after the primary endpoint of a Phase III trial was not met; Teva was still developing it for episodic cluster headache and migraine. Se...
Read more Fremanezumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fremanezumab
Recent Fremanezumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 150mg/ml
Other drugs which contain Fremanezumab or a similar ingredient: (1 result)
- AJOVY Fremanezumab-vfrm